#1292ef

Biogen

#f9f9f9

Michel Vounatsos

Susan Alexander

Alphonse Galdes

Ginger Gregory

Chirfi Guindo

Michael Mcdonnell

Alfred Sandrock

Alisha A Alaimo

Rachid Izzar

Natacha Gassenbach

Maha Radhakrishnan

Minita Shah Mara

Priya Singhal

Denna Wanner Williams

Rob Posgai

Amila Kasamovic

David Tateosian

Nicole Shippee

Megan Rodriguez

Andrew Alicea

Tejaswini Sharma

Desmond Kennedy

Melvin Baskett

Keith Bazinet

Anthony M Howarth

Ron Haley

Deepti Vasave

Fal Vaidya

Jeff Spencer

Angela Williams

Jennifer Sloan

Christina Moscone

Thomas A Maniscalco

Eric Welsh

Lindsay Falone

Alison Griffith

Francesca Simoni

Kendall Phillips

Kent Walker

Hasim K.

Michael Friedman

Margaret Bush

Barry Crabtree

Andrew White

Gwendolyn Bethea

Jiali Chloe Chen

Matthew Marzetti

Ayushi Kedar

Kaushik Meneni

Paul Orlinsky

Brian Hood

Adam Sheriff

Amanda Lofton Scott

Jayanth Venkatachalam

Imran Shakur

Shawn Malloy

Jacquelyn Amico

Leslie Mauriello

Carl Teghtmyer

Jennifer Case

Maria Elena Gonzalez

John Mcfadden

Carlos Maldonado

Christine Chace

Madhurya Baruah

Blake Simpson

Michael Grimaldi

Eric Winrow

Chandra Pandey

Zack Li

Cameron Huskey

Katie Kopycinski

Lance Price

Zhongkun Lyu

Melissa Saverse

Josh Lyons

Steve Witham

Laura Doremus

Buket Grau

Zach Pepper-Cunningham

Randy Smith

Brendan D

#87c5f2

Corporate

Legal Officer and Secretary

Pharmaceutical Operations and Technology

Human Resources

Global Product Strategy & Commercialization

Finance

Research and Development

President Biogen U.S. Organization

Biogen Intercontinental Region

Communications & Corporate Affairs

Medical

Organization Effectiveness and Diversity and Inclusion

Global Safety & Regulatory Sciences

Procurement

G&A, Global Procurement

R&D Procurement

Analytics Global Procurement

We are a biotechnology leader that discovers, develops and delivers innovative therapies to improve the lives of patients with neurodegenerative diseases, hematologic conditions and autoimmune ... 

Who We Are
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Focus on Neuroscience
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Corporate Responsibility
Biogen contributes to the communities where we live. We are committed to our employees, diversity, equity and inclusion, and environmental sustainability.
Together, we pioneer. Together, we thrive.
We came to Biogen to solve the unsolvable. We stay to create new possibilities and grow together. We work fearlessly and go beyond because we care deeply about making a difference and changing lives. All legitimate correspondence from a Biogen employee will come from “@biogen.com” or “@smartrecruiters.com” email accounts.
U.S. FDA approves ADUHELM™ (aducanumab-avwa) for Alzheimer’s disease
Read more
An open letter to the Alzheimer’s disease community from our Head of Research and Development, Alfred Sandrock, M.D., Ph.D.
Read more
When Kamaria's mother, Mary, was diagnosed with early-onset Alzheimer's, it didn't just change Mary's life. It changed the lives of her whole family. September is World Alzheimer’s month, and Biogen stands together with patients, caregivers, healthcare providers and advocates around the world in the fight against this devastating disease.
For Junghae Suh, head of Biogen’s Gene Therapy Accelerator Unit, it’s about working to deliver potentially life-transforming gene therapy medicines to patients.
Biogen is committed to the power of diversity – in our organization and among our patients and customers. Diversity is an essential asset of complementary strengths and perspectives from which all benefit, and which must unite us, not divide us.
Science that transforms patient lives. Science that seeks to solve societal problems. Science that acts with purpose. Science that is inspired by the diversity and passion of our people. Discover where science meets humanity at Biogen.
Read our stories
“Our goal is to deliver innovative therapies for patients and invest in the areas of highest return to deliver long-term value to our stockholders.”
Meet Keecia.
Keecia is the medical partner that provides relevant, reliable, and unbiased scientific information to Biogen’s internal and external customers.
You are now leaving Biogen’s corporate website.
We encourage you to read and evaluate terms of use, privacy, security and other similar policies of the destination site as they may differ from Biogen’s standards.
Third Party Sites
Biogen assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of Biogen or this website.


We believe in improving the quality of patient care by supporting medical research that advances scientific knowledge of disorders relevant to our therapeutic portfolio and products.